Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations

EMBO Journal

Volumn 15, Issue 7, 1996, Pages 1615-1624

  Léveillard, Thierry ^a   Andera, Ladislav ^a   Bissonnette, Nathalie ^a,c   Schaeffer, Laurent ^a   Bracco, Laurent ^b   Egly, Jean Marc ^a   Wasylyk, Bohdan ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b SANOFI   (France)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Cell cycle control; DNA repair; Transcription; Tumour suppressor; Xeroderma pigmentosum

Indexed keywords

HELICASE; MUTANT PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 0029880959     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00506.x     Document Type: Article

References (99)

1. Akoulitchev, S., Mäkelä, T.P., Weinberg, R.A. and Reinberg, D (1995) Requirement for TFIIH kinase activity in transciption by RNA polymerase II. Nature, 377, 557-560.
2. Bakalkin, G., Yakovleva, T., Selivanova, G., Magnusson, K.P., Szekely, E., Klein, G., Teremus, L. and Wiman, K.G. (1994) p53 binds single-stranded DNA ends and catalyses DNA renaturation and strand transfer. Proc. Natl Acad. Sci. USA, 91, 413-117.
3. Bakalkin, G. et al. (1995) p53 binds single-stranded DNA ends through the C-termmal domain and internal DNA segments via the middle domain. Nucleic Acids Res., 23, 362-369.
4. Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K.U. and Vogelstein, B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912-915.
5. Bargonetti, J., Manfredi, J.J., Chen, X., Marshak, D.R. and Prives, C. (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev., 7, 2565-2574.
6. Bodmer, W., Bishop, T. and Karran, P. (1994) Genetic steps in colorectal cancer. Nature Genet., 6, 217-219.
7. Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223.
8. Caron de Fromentel, C. and Soussi, T. (1992) TP53 tumor suppressor gene: a model for investigating human mutagenesis. Gene Chromosomes Cancer, 4, 1-15.
9. Cho, Y., Gorina, S., Jeffrey, P.D. and Pavletich, N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations Science, 265, 346-355.
10. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L and Wyllie, A.H.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
11. Clore, G.M., Ernst, J., Cubb, R., Omichinski, J.G., Poindexter Kennedy, W M., Sakagushi, K., Appella, E. and Gronenborn, A.M. (1995) Refined solution structure of the oligomerisation domain of the tumour suppressor p53. Nature Struct Biol., 2, 321-333.
12. Cox, L.S., Hupp, T., Midgley, C.A. and Lane, D.P. (1995) A direct effect of activated human p53 on nuclear DNA replication. EMBO J., 14, 2099-2105.
13. Dittmer, D., Pati, S , Zambetti, G., Chu, S., Teresky, A.K., Moore, M., Finlay, C. and Levine, A.J. (1993) Gain of function mutations in p53. Nature Genet , 4, 42-45.
14. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr. Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221
15. Drapkin, R., Reardon, J.T., Ansari, A., Huang, J.C., Zawel, L., Ahn, K., Sancar, A. and Reinberg, D. (1994) Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature, 368, 769-772.
16. Dubs-Poterszman, M.C., Tocque, B. and Wasylyk, B. (1995) MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. Oncogene, 11, 2445-2449.
17. Dutta, A , Ruppert, J.M., Aster, J.C. and Winchester, E. (1993) Inhibition of DNA replication factor RPA by p53 Nature, 365, 79-82.
18. El-Deiry, W.S. et al. (1993) WAF-1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
19. Feaver, W.J , Svejstrup, J.Q., Bardwell, L., Bardwell, A.J., Buratowski, S., Gulyas, K.D., Donahue, T.F., Friedberg, E.C. and Kornberg, R.D. (1993) Dual roles of a multiprotein complex from S.cerevisiae in transcription and DNA repair. Cell, 75, 1379-1387.
20. Feaver, W J., Svejstrup, J.Q., Henry, N.L. and Kornberg, R.D. (1994) Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell, 79, 1103-1109.
21. Fields, S. and Jang, S.K. (1990) Presence of a potent transcription activating sequence in the p53 protein. Science, 249, 1046-1048.
22. Fisher, F , Gerard, M., Chalut, C., Lutz, Y., Humbert, S., Kanno, M., Chambon, P. and Egly, J.M. (1992) Cloning of the 62-Kilodalton component of basic transcription factor BTF2 Science, 257, 1392-1395.
23. Fisher, R.P. and Morgan, D.O. (1994) A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell, 78, 713-724.
24. Flejter, W.L., McDaniel, L.D., Johns, D., Friedberg, E.C. and Schutz, R.A. (1992) Correction of xeroderma pigmentosum complementation group D mutant cell phenotype by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene. Proc. Natl Acad. Sci. USA, 89, 261-265.
25. Flores, O., Lu, H and Reinberg, D. (1992) Factors involved in specific transcription by mammalian RNA polymerase II. J. Biol. Chem., 267, 2786-2793.
26. Ford, J.M. and Hanawalt, P.C (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl Acad Sci. USA, 92, 8876-8880.
27. Gerard, M., Fisher, L., Moncollin, V , Chipoulet, J.M., Chambon, P. and Egly, J.M. (1991) Purification and interaction properties of the human RNA polymerase B (II) general transcription factor BTF2. J. Biol. Chem., 266, 20940-20945.
28. Goodrich, J.A. and Tjian, R. (1994) Transcription factor IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II. Cell. 77, 145-156.
29. Hannon, G.J., Demetrick, D. and Beach, D. (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev., 7, 2378-2391.
30. Harris, C.C. (1993) p53 at the crossroads of molecular carcinogenesis and risk assessment. Science, 262, 1980-1981.
31. Haupt, Y , Rowan, S., Shaulian, E., Vousden, K.H and Oren, M. (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9, 2170-2183.
32. Havre, P.A., Yuan, J., Hedrick, L., Cho, K.R. and Glazer, P.M. (1995) p53 inactivation by HPV16 results in increased mutagenesis in human cells. Cancer Res., 55, 4420-4424.
33. Hinds, P W., Finlay, C.A., Quartin, R S., Baker, S , Fearon, E.R., Vogelstein, B. and Levine, A J. (1990) Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells: a comparison of the 'hot spot' phenotypes. Cell Growth Differ., 1, 571-580.
34. Hoeijmakers, J.H.J (1993) Nucleotide excision repair II: from yeast to mammals. Trends Genet., 9, 211-217.
35. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C (1991) p53 mutations in human cancers. Science, 253, 49-53.
36. Horikoshi, N., Usheva, A., Chen, J., Levine, A.J , Weinmann, R. and Shenk, T. (1995) Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol. Cell. Biol., 15, 227-234.
37. Hupp, T.R., Meek, D.W., Midgley, C.A. and Lane, D.P. (1992) Regulation of the specific DNA binding function of p53. Cell. 71, 875-886.
38. Hupp, T.R., Sparks, A. and Lane, D.P. (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell, 83, 237-245.
39. Ishizaki, K , Ejima, Y., Matsunaga, T., Hara, R., Sakamoto, A., Ikenaga, M., Ikawa, Y. and Aizawa, S.I. (1994) Increased UV-induced SCEs but normal repair of DNA damage in p53-deficient mouse cells. Int. J. Cancer, 57, 254-257.
40. Jayaraman, L. and Prives, C. (1995) Activation of sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell, 81, 1021-1029.
41. Jeffrey, P.D., Gorina, S. and Pavletich, N.P. (1995) Crystal structure of the tetramerization domain of the p53 tumour suppressor at 1.7 angströms. Science, 267, 1498-1502.
42. Kastan, M.B., Onyiye, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
43. Kazantsev, A., Sancar, A., Kearsey, J.M , Shivji, M.K.K., Hall, P.A. and Wood , R.D. (1995) Does the p53 up-regulated Gadd45 protein have a role in excision repair? Science. 270, 1003-1006.
44. Lane, D.P (1992) p53, guardian of the genome. Nature, 358, 15-16.
45. Lane, D.P. (1993) A death in the life of p53. Nature, 362, 786-787.
46. Lee, S., Elenbaas, B., Levine, A.J. and Griffith, J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell, 81, 1013-1020.
47. Lee, W S., Kao, C.C., Bryant, G.O., Liu, X. and Berk, A.J. (1991) Adenovirus E1 A activation domain binds the basic repeat in the TATA box transcription factor. Cell, 67, 365-376.
48. Léveillard, T and Verma, I. (1993) Diverse molecular mechanisms of inhibition of NF-κB/DNA binding complexes by IκB proteins. Gene Exp , 3, 135-150.
49. Liu, X., Miller, C.W., Koeffler, P.H. and Berk, A.J. (1993) The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and neighboring p53 domain inhibits transcription. Mol. Cell. Biol., 13, 3291-3300.
50. Livinstone, L R., White, A., Sprouse, J., Livanos, E., Jacks, T. and Tlsty, T.D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935.
51. Lowe, S.W., Schmitt, E M , Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
52. II31 protein is transcriptional coactivator of the p53 protein. Proc. Natl Acad Sci. USA, 92, 5154-5158.
53. Lu, H., Zawel, L., Fisher, L., Egly, J.M. and Reinberg, D. (1992) Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature, 358, 641-645.
54. Ludlow, J.W. (1993) Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J., 7, 866-871.
55. Mack, D.H., Vartikar, J., Pipas, J.M. and Laimins, L.A. (1993) Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53 Nature, 363, 281-283.
56. Maxon, M.E., Goodrich, J.A. and Tjian, R. (1994) Transcription factor IIE binds preferentially to RNA polymerase IIa and recruits TFIIH: a model for promoter clearance. Genes Dev., 8, 515-524.
57. Meek, D.W., Simon, S., Kikkawa, U. and Eckhart, W. (1990) The p53 tumour suppressor protein is phosphorylated at senne 389 by casein kinase II. EMBO J., 9, 3253-3260.
58. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299
59. Momand, J., Zambetti, G.P., Olson, D.C., George, D. and Levine, A.J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
60. Oberosler, P., Hloch, P., Ramsperger, U. and Stahl, H. (1993) p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J., 12, 2389-2396
61. Ohkuma, Y. and Roeder, R.G. (1994) Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation of complex formation. Nature, 368, 160-163.
62. Ossipow, V. Tassan, J.P., Nigg, E.A. and Schibler, U. (1995) A mammalian RNA polymerase II holoenzyme containing all components required for promoter-specific transcription initiation. Cell, 83, 137-146
63. Parvin, J.D. and Sharp, P.A. (1993) DNA topology and a minimal set of basal factors for transcription by RNA polymerase II. Cell, 73, 533-540.
64. Pavletich, N.P., Chambers, K.A. and Pabo, C.O. (1993) The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev., 7, 2556-2564.
65. Reed, M., Wang, Y., Mayr, G., Anderson, M.E., Schwedes, J.F. and Tegtmeyer, P. (1993) p53 domains: suppression, transformation, and transactivation. Gene Exp., 3, 95-106.
66. Reed, M., Woelker, B., Wang, P., Wang, Y., Anderson, M E. and Tegtmeyer, P. (1995) The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl Acad. Sci. USA, 92. 9455-9459.
67. Roy, R., Adamczewski, J.P., Seroz, T., Vermeulen, W., Tassan, J.P., Schaeffer, L., Nigg, E.A., Hoeijmakers, J.H.J. and Egly, J.M. (1994) The MOI5 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell, 79, 1093-1101.
68. Sakurai, T., Suzuki, M., Sawazaki,T., Ishii, S. and Yoshida, S. (1994) Anti-oncogene product p53 binds DNA helicase. Exp. Cell Res., 215, 57-62.
69. Sancar, A. (1995) Excision repair in mammalian cells. J. Biol. Chem., 270, 15915-15918.
70. Sands, A.T., Sukaokar, M.B., Sanchez, A., Marth, I.E., Donehower, L.A. and Bradley, A. (1995) p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc. Natl Acad. Sci. USA, 92, 8517-8521.
71. Schaeffer, L., Roy, R., Humbert, S., Moncollin, V., Vermeulen, W., Hoeijmakers, J.H.J., Chambon, P. and Egly, J.M. (1993) DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science, 260, 58-63.
72. Schaeffer, L., Moncollin, V., Roy, R., Staub, A., Mezzina, M., Sarasin, A., Weeda, G., Hoeijmakers, J.H J. and Egly, J M. (1994) The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J , 13, 2388-2392.
73. Seroz, T., Hwang, J.R., Moncollin, V. and Egly, J M. (1995) TFIIH: a link between transcription, DNA repair and cell cycle regulation. Curr. Opin. Genet. Dev. 5, 217-221.
74. Seto, E., Usheva, A., Zambetti, G.P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A.J. and Shenk, T. (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad. Sci. USA, 89, 12028-12032.
75. Shaulian, E., Zauberman, A., Ginsberg, D. and Oren, M. (1992) Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell Biol , 12, 5581-5592.
76. Shaulian, E., Haviv, I , Shaul, Y. and Oren, M. (1995) Transcriptional repression by the C-terminal domain of p53. Oncogene. 10, 671-680.
77. Shaw, P. Bovey, R., Tardy, S , Sahli, R., Sordat, B. and Costa, J (1992) Induction of apoptosis by wild-type p53 Proc Natl Acad. Sci. USA, 89, 4495-4499.
78. Shibata, D., Pemado, M.A., Ionov, Y., Malkhosyan, S. and Perucho, M. (1994) Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet., 6, 273-281.
79. Shiekhattar, R., Mermelstein, F., Fisher, R.P., Drapkin, R., Dynlatch, B., Wessling, H.C., Morgan, D.O. and Reinberg, D. (1995) Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature, 374, 283-287.
80. Smith, M.L., Chen, I.T., Zhan, Q., Bae, I., Chen, C.Y., Gilmer, T.M., Kastan, M.B., O'Connor, P.M. and Fornace, A.J., Jr (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science, 266, 1376-1380
81. Smith, M.L., Chen, I.T., Zhan, Q., O'Connor, P.M. and Fornace, A.J., Jr (1995) Involvement of the p53 tumor suppressor in repair of u.v-type DNA damage. Oncogene, 10, 1053-1059.
82. Stürzbecher, H.-W., Brain, R., Addison, C., Rudge, K., Remm.M., Grimaldi.M., Keenan.E. and Jenkins, J.R. (1992) A C-terminal α-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene, 7, 1513-1523.
83. Tong, X., Drapkin, R., Reinberg, D. and Kieff, E. (1995) The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2. Proc. Natl Acad. Sci. USA, 92, 3259-3263.
84. Truant, R., Xiao, H., Ingles, C.J. and Greenblatt, J. (1993) Direct interaction between the transcription activation domain of human p53 and the TATA box-binding protein. J. Biol. Chem., 268, 2284-2287.
85. van Vuuren, A.J. et al. (1994) Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH). EMBO J., 13, 1645-1653.
86. Wang, E.H., Friedman, P.N. and Prives, C. (1989) The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen. Cell, 57, 379-392.
87. Wang, X.W., Forrester, K , Yeh, H., Feitelson, M.A., Gu, J.R. and Harris, C.C. (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl Acad. Sci. USA. 91, 2230-2234.
88. Wang, X.W. et al. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet., 10, 188-195.
89. Wang, Y. and Prives, C. (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature, 376, 88-91.
90. Wang, Y., Reed, M., Wang, P., Stenger, J.E., Mayr, G., Anderson, M.E., Schwedes, J.F. and Tegtmeyer, P. (1993) p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev., 7, 2575-2586.
91. Weber, C.A., Salazar, E P., Stewart, S.A. and Thompson, L.H. (1990) ERCC2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J., 9, 1437-1447.
92. Weeda, G., van Ham, R.C.A., Vermeulen, W., Bootsma, D., van der Eb, A J. and Hoeijmakers, J.H.J. (1990) A presumed DNA helicase encoded by ERCC-3 is involved in the human DNA repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell, 62, 777-791.
93. Wood, R.D., Biggerstaff, M. and Shivji, M.K.K. (1995) Detection and measurement of nucleotide excision repair synthesis by mammalian cell extracts in vitro. Methods: A companion to Methods in Enzymology. 7, 163-175.
94. Wu, W., Bayle, H., Elenbaas, B., Pavletich, N P. and Levine, A.J. (1995) Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids. Mol. Cell. Biol., 15, 497-504.
95. Xiao, H. et al (1994) Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol., 14, 7013-7024.
96. Yew, P.R. and Berk, A.J. (1992) Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature, 357, 82-85
97. Yin, Y , Tamsky, M.A., Bishoff, F.Z., Strong, L.C. and Wahl, G.M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles Cell, 70, 937-948
98. Yonish-Rouach, E., Resmtzky, D., Lotem, J., Sachs, L., Kimchi, A and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukeamic cells that is inhibited by interleukin-6. Nature, 352, 345-347.
99. Zawel, L., Kumar, K.P. and Reinberg, D. (1995) Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev., 9, 1479-1490.